PCL films incorporated with paclitaxel/5-fluorouracil: Effects of formulation and spacial architecture on drug release

International Journal of Pharmaceutics

Volumn 427, Issue 2, 2012, Pages 242-251

  Rong, Hao Jun ^a   Chen, Wei Luan ^a   Guo, Sheng Rong ^a   Lei, Lei ^a   Shen, Yuan Yuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

5 Fluorouracil; Drug release; Film; Paclitaxel; PCL

Indexed keywords

FLUOROURACIL; PACLITAXEL; POLYCAPROLACTONE;

ARTICLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MECHANISM; DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLORING AGENTS; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG-ELUTING STENTS; FEMALE; FLUOROURACIL; MICE; MICROSCOPY, ELECTRON, SCANNING; PACLITAXEL; POLYESTERS; POLYETHYLENE GLYCOLS; SOLUBILITY; SPECTROPHOTOMETRY, ULTRAVIOLET; SURFACE PROPERTIES; TETRAZOLIUM SALTS; THIAZOLES; X-RAY DIFFRACTION;

EID: 84862784567     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.02.007     Document Type: Article

References (31)

1. J. Ako, H.N. Bonneau, Y. Honda, and P.J. Fitzgerald Design criteria for the ideal drug-eluting stent Am. J. Cardiol. 100 2007 3M 9M
2. L.P. Cavalcanti, O. Konovalov, and H. Haas X-ray diffraction from paclitaxel-loaded zwitterionic and cationic model membranes Chem. Phys. Lipids 150 2007 58 65
3. W.L. Chen, Y.Y. Shen, H.J. Rong, L. Lei, and S.R. Guo Development and application of a validated gradient elution HPLC method for simultaneous determination of 5-fluorouracil and paclitaxel in dissolution samples of 5-fluorouracil/paclitaxel-co-eluting stents J. Pharm. Biomed. Anal. 59 2012 179 183
4. L. Cheng, S.R. Guo, and W.P. Wu Characterization and in vitro release of praziquantel from poly(epsilon-caprolactone) implants Int. J. Pharm. 377 2009 112 119
5. L. Cheng, L. Lei, and S. Guo In vitro and in vivo evaluation of praziquantel loaded implants based on PEG/PCL blends Int. J. Pharm. 387 2010 129 138
6. L. Cheng, L. Lei, and S.R. Guo In vitro and in vivo evaluation of praziquantel loaded implants based on PEG/PCL blends Int. J. Pharm. 387 2010 129 138
7. P. Costa, J. Manuel, and S. Lobo Modeling and comparison of dissolution profiles Eur. J. Pharm. Sci. 13 2001 123 133
8. J.-F. Feng, J.-W. Lu, and X.-F. Sun Biweekly regimen of high dose of leucovorin, 5-fluorouracil, and paclitaxel for patients with advanced gastric cancer Ai Zheng Chin. J. Cancer 23 2004 1704 1706
9. Q.H. Guo, S.R. Guo, and Z.M. Wang Estimation of 5-fluorouracil-loaded ethylene-vinyl acetate stent coating based on percolation thresholds Int. J. Pharm. 333 2007 95 102
10. Q.Y. Guo, P.T. Knight, and P.T. Mather Tailored drug release from biodegradable stent coatings based on hybrid polyurethanes J. Control. Release 137 2009 224 233
11. R.S. Gupta Cross-resistance of vinblastine- and taxol-resistant mutants of Chinese hamster ovary cells to other anticancer drugs Cancer Treat. Rep. 69 1985 515 521
12. A. Gupte, and K. Ciftci Formulation and characterization of paclitaxel, 5-FU and paclitaxel+5-FU microspheres Int. J. Pharm. 276 2004 93 106
13. T. Higuchi Rate of release of medicaments from ointment bases containing drugs in suspension J. Pharm. Sci. 50 1961 874 875
14. J.-W. Lee, J.-K. Park, S.-H. Lee, S.-Y. Kim, Y.-B. Cho, and H.-J. Kuh Anti-tumor activity of heptaplatin in combination with 5-fluorouracil or paclitaxel against human head and neck cancer cells in vitro Anticancer Drugs 17 2006 377 384
15. L. Lei, S.R. Guo, W.L. Chen, H.J. Rong, and F. Lu Stents as a platform for drug delivery Expert. Opin. Drug Deliv. 8 2011 813 831
16. L. Lei, X. Liu, S.R. Guo, M.F. Tang, L.A. Cheng, and L. Tian 5-Fluorouracil-loaded multilayered films for drug controlled releasing stent application: drug release, microstructure, and ex vivo permeation behaviors J. Control. Release 146 2010 45 53
17. L. Lei, X. Liu, Y.Y. Shen, J.Y. Liu, M.F. Tang, Z.M. Wang, S.R. Guo, and L. Cheng Zero-order release of 5-fluorouracil from PCL-based films featuring trilayered structures for stent application Eur. J. Pharm. Biopharm. 78 2011 49 57
18. U. Little, F. Buchanan, E. Harkin-Jones, M. McCaigue, D. Farrar, and G. Dickson Accelerated degradation behaviour of poly(epsilon-caprolactone) via melt blending with poly(aspartic acid-co-lactide) (PAL) Polym. Degrad. Stab. 94 2009 213 220
19. X. Liu, L. Lei, J.W. Hou, M.F. Tang, S.R. Guo, Z.M. Wang, and K.M. Chen Evaluation of two polymeric blends (EVA/PLA and EVA/PEG) as coating film materials for paclitaxel-eluting stent application J. Mater. Sci. Mater. Med. 22 2011 327 337
20. D.B. Longley, D.P. Harkin, and P.G. Johnston 5-Fluorouracil: mechanisms of action and clinical strategies Nat. Rev. Cancer 3 2003 330 338
21. J.J. Monsuez, J.C. Charniot, N. Vignat, and J.Y. Artigou Cardiac side-effects of cancer chemotherapy Int. J. Cardiol. 144 2010 3 15
22. J. Petrovic, S. Ibric, J. Jockovic, J. Parojcic, and Z. Duric Determination of the percolation thresholds for polyethylene oxide and polyacrylic acid matrix tablets J. Drug Deliv. Sci. Technol. 19 2009 359 364
23. P.L. Ritger, and N.A. Peppas A simple equation for description of solute release II. Fickian and anomalous release from swellable devices J. Control. Release 5 1987 37 42
24. D. Rohner, D.W. Hutmacher, P. See, K.C. Tan, V. Yeow, S.Y. Tan, S.T. Lee, and B. Hammer Individually CAD-CAM technique designed, bioresorbable 3-dimensional polycaprolactone framework for experimental reconstruction of craniofacial defects in the pig Mund Kiefer Gesichtschir. 6 2002 162 167
25. M. Sairam, V.R. Babu, B.V.K. Naidu, and T.M. Aminabhavi Encapsulation efficiency and controlled release characteristics of crosslinked polyacrylamide particles Int. J. Pharm. 320 2006 131 136
26. V.R. Sinha, K. Bansal, R. Kaushik, R. Kumria, and A. Trehan Poly-epsilon-caprolactone microspheres and nanospheres: an overview Int. J. Pharm. 278 2004 1 23
27. M. Sugimura, S. Sagae, S. Ishioka, Y. Nishioka, K. Tsukada, and R. Kudo Mechanisms of paclitaxel-induced apoptosis in an ovarian cancer cell line and its paclitaxel-resistant clone Oncology 66 2004 53 61
28. T. Tsuji, H. Tamai, K. Igaki, E. Kyo, K. Kosuga, T. Hata, T. Nakamura, S. Fujita, S. Takeda, S. Motohara, and H. Uehata Biodegradable stents as a platform to drug loading Int. J. Cardiovasc. Intervent. 5 2003 13 16
29. R. Waksman, and K. Wakabayashi Biodegradable polymer for drug-eluting stents - a true advantage or only perception? Circ. J. 74 2010 2052 2053
30. H. Watari, M. Hosaka, T. Mitamura, M. Moriwaki, Y. Ohba, Y. Todo, M. Takeda, Y. Ebina, and N. Sakuragi Weekly paclitaxel/5-fluorouracil followed by platinum retreatment for patients with recurrent ovarian cancer: a single institution experience Eur. J. Gynaecol. Oncol. 29 2008 573 577
31. M. Zilberman, and R.C. Eberhart Drug-eluting bioresorbable stents for various applications Annu. Rev. Biomed. Eng. 2006 153 180